期刊文献+

细胞免疫治疗的研究进展及应用 被引量:1

Progress and application of cellular immunotherapy
原文传递
导出
摘要 自身免疫性疾病(AID)和肿瘤的发病率高,严重影响患者的生存质量和寿命。近年来,细胞免疫治疗取得了巨大进展,已成为AID和肿瘤治疗的重要发展方向。越来越多的研究表明细胞免疫治疗能缓解甚至逆转AID和肿瘤的疾病进程。本文简要概述了细胞免疫治疗在AID和肿瘤研究中的进展和临床应用潜能。 Incidence of autoimmune diseases (AID) and tumors has increased dramatically, which seriously affects the survival and the quality of life in patients. Recently, cellular immunotherapy has become more and more attractive in the treatment of AID and tumors. Emerging studies have shown that cellular immunotherapy can alleviate or even reverse the course of AID and tumors. We reviewed to focus on the advances of cellular immunotherapy in AID and tumors.
作者 俞海波 周智广 Yu Haibo Zhou Zhiguang(Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Met- abolic Diseases, Changsha 410011, China)
出处 《中国医师杂志》 CAS 2017年第1期1-3,共3页 Journal of Chinese Physician
基金 国家重点研发计划(2016YFE0107500) 国家自然科学基金(81402272) 中南大学“创新驱动计划”项目(2015CX009)
关键词 免疫疗法 组织疗法 肿瘤/治疗 自身免疫疾病/治疗 综述 Immunotherapy Tissue therapy Neoplasms/TH Autoimmune diseases/TH ~ Review
  • 相关文献

参考文献1

二级参考文献30

  • 1Mackay IR.Travels and travails of autoimmunity:a historical journey from discovery to rediscovery[J].Autoimmun Rev,2010,9(5):A251-A258.
  • 2Cárdenas-Roldán J,Rojas-Villarraga A,Anaya JM.How do autoimmune diseases cluster in families? A systematic review and meta-analysis[J].BMC Med,2013,11:73.
  • 3Ben-Ami Shor D,Harel M,Eliakim R,et al.The hygiene theory harnessing helminths and their ova to treat autoimmunity[J].Clin Rev Allergy Immunol,2013,45(2):211-216.
  • 4Kremer JM,Russell AS,Emery P,et al.Long-term safety,efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate:3-year results from the AIM trial[J].Ann Rheum Dis,2011,70(10):1826-1830.
  • 5Grijalva CG,Chen L,Delzell E,et al.Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases[J].JAMA,2011,306(21):2331-2339.
  • 6Jain A,Singh JA.Harms of TNF inhibitors in rheumatic diseases:a focused review of the literature[J].Immunotherapy,2013,5(3):265-299.
  • 7Burmester GR,Feist E,Kellner H,et al.Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis:the first phase IIIb real-life study (TAMARA)[J].Ann Rheum Dis,2011,70(5):755-759.
  • 8Merrill JT,Wallace DJ,Petri M,et al.Safety profile and clinical activity of sifalimumab,a fully human anti-interferon α monoclonal antibody,in systemic lupus erythematosus:a phase I,multicentre,double-blind randomised study[J].Ann Rheum Dis,2011,70(11):1905-1913.
  • 9Petri M,Wallace DJ,Spindler A,et al.Sifalimumab,a human anti-interferon-α monoclonal antibody,in systemic lupus erythematosus:a phase I randomized,controlled,dose-escalation study[J].Arthritis Rheum,2013,65(4):1011-1021.
  • 10Rosman Z,Shoenfeld Y,Zandman-Goddard G.Biologic therapy for autoimmune diseases:an update[J].BMC Med,2013,11:88.

共引文献4

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部